This year brings several major healthcare policy changes for patients. While some of these changes improve healthcare access and affordability, two key decisions could have a detrimental impact on ...
In today’s Pharma Pulse, the biopharma landscape enters a transformative phase as the US signs landmark PBM reforms into law, ...
Roth began by sharing what he believes to be the single-most important characteristic of pharma company long-term survival ...
1. FTC Secures Landmark Settlement with Express Scripts to Lower Drug Costs for American Patients. United States Federal Trade Commission. February 4, 2026. Accessed February 5, 2026.
The combination of GENEROUS for Medicaid, Globe for Medicare Part B and Guard for Medicare Part D will heavily impact the US drug market. President Trump’s rhetoric has been that other countries ...
In today’s Pharma Pulse, AstraZeneca faces a complete response letter for its self-injectable lupus drug, while the EMA gives ...
By unifying data, workflows, and decision-making across partners, AI orchestration is enabling healthcare supply chains to ...
ORBIS Corporation's acquisition of Robinson Industries enhances manufacturing capabilities and accelerates production ...
In the final part of his Pharma Commerce video interview, Joe Hudicka, entrepreneur and supply chain expert, outlines how real-time AI signal sharing across supply chain partners can help pharma ...
Körber, a provider of manufacturing and supply chain solutions—including for the pharma industry—has struck a deal to acquire ...
Hudicka also comments on practical steps can supply chain leaders take to build trust in AI-driven ecosystems without ...
In the first part of his Pharma Commerce video interview, Joe Hudicka, entrepreneur and supply chain expert, explains how ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results